Lincoln Pharmaceuticals has informed that the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available.
The above information is a part of company’s filings submitted to BSE.